公司資料
Summit Therapeutics 股價、新聞與催化劑
- 股票代碼:
- SMMT
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United Kingdom with U
股票表現
12.78 USD (-4.27%)
收盤價
最後更新: 2026年8月17日
11.5B USD
市值
股價為何變動
As of Aug 17, 2026, SMMT closed down 4.27% at $12.78. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Summit Therapeutics is a biopharmaceutical company centered on oncology and the commercial potential of its lead cancer programs. The company has become a market focus because of its high-profile clinical and strategic story.
所在地與產業分類
Headquartered in the United Kingdom with U.S. market exposure and listed on NASDAQ, Summit sits in oncology biotechnology.
商業模式特徵
Its model is driven by clinical data, partnering, and the possibility of turning a focused oncology program into a major value driver.
生技產業定位
Summit is a high-beta oncology name where data and strategic developments can quickly dominate the valuation.
未來催化劑
- Summit Therapeutics's catalysts are ivonescimab development and the next oncology readouts that could keep the PD-1 / VEGF story moving. The company matters most when the clinical data stay ahead of the hype.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。